Nxera Pharma receives approval of insomnia drug in Japan

Nxera Pharma, formerly known as Sosei Group or Sosei Heptares, has received approval from the Ministry of Health, Labour...

September 24, 2024 | Tuesday | News
Antengene receives approval to commercialise XPOVIO in Thailand for multiple myeloma patients

China-based Antengene Corporation has announced that the Thailand Food and Drug Administration has approved a ...

September 23, 2024 | Monday | News
Australia's Telix Pharma buys RLS (USA) for $230 M to build next gen radiometal production network

Australia-headquartered Telix Pharmaceuticals and RLS (USA) Inc., America's only Joint Commission-accredited radiopharma...

September 23, 2024 | Monday | News
Japan's Takeda Pharma provides over $32 M for five new global CSR partnerships

Japanese pharma firm Takeda has awarded JPY 4.6 billion (approximately $32 million) to five new partners in the field of...

September 20, 2024 | Friday | News
BD expands capacity for advanced prefillable syringes and enhances injection experience for next-gen biologics

BD (Becton, Dickinson and Company), a leading global medical technology company, has announced the commercial release of...

September 18, 2024 | Wednesday | News
BIOCHINA 2025: China's Largest Bio Convention to Host Over 3,000 Biotech Companies

Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...

September 12, 2024 | Thursday | News
Israel's Moebius Medical & India's Sun Pharma receive fast track designation for osteoarthritis knee pain medicine

India-based Sun Pharma and Israel-based Moebius Medical have announced that the US Food and Drug Administration (FD...

September 6, 2024 | Friday | News
Taiwan's Tanvex BioPharma appoints Stephen Lam as CEO

Tanvex BioPharma, Inc., Taiwan-based biosimilar-focused biopharmaceutical company and a contract development and manufac...

September 5, 2024 | Thursday | News
Japanese pharma firm Astellas unveils new life sciences centre in US to accelerate discovery of breakthrough therapies

Japan-based Astellas Pharma Inc. has officially opened its new Astellas Life Sciences Centre (ALSC) in Ca...

September 5, 2024 | Thursday | News
US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets

US-based Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorders and canc...

September 5, 2024 | Thursday | News
Strategic GenAI adoption to revolutionise Life Sciences sector: Report

US-based HFS Research has released a report in collaboration with Indegene, elaborating how Generative AI (Gen...

September 4, 2024 | Wednesday | News
Japan's Rigaku Corp develops solution to accelerate biopharmaceutical R&D

Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab in Japan, has ...

September 4, 2024 | Wednesday | News
Health Ministry in UAE to create national scientific guide for tackling obesity and weight management

The Ministry of Health and Prevention (MoHAP), in United Arab Emirates (UAE), has teamed up with Novo Nordisk Pharma Gul...

September 3, 2024 | Tuesday | News
Hasten Biopharma joins hands with DKSH to improve treatment of chronic diseases in Thailand

DKSH Business Unit Healthcare, a strategic healthcare solutions partner and leading provider of market expansion service...

September 3, 2024 | Tuesday | News
mRNA as novel active ingredient – PlasmidFactory providing the template for tomorrow's vaccines

  Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...

September 2, 2024 | Monday | News
Rebooting Japan's biotech growth engine

On July 30 2024, Japanese Prime Minister Fumio Kishida unveiled a roadmap to establish Japan as a ‘drug discovery ...

September 1, 2024 | Sunday | Analysis
Zuellig Pharma & Regeneron take cancer drug Libtayo to Korea and Taiwan markets

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with R...

August 29, 2024 | Thursday | News
CPHI Korea 2024 opens with 15% growth as innovation booms in Korea

CPHI Korea, at the heart of Korea’s pharmaceutical industry, opened on 27th August, as both the event and cou...

August 28, 2024 | Wednesday | News
GenScript offers new hope for multiple myeloma patients in China

Legend Biotech, a subsidiary of GenScript Biotech Corporation, a global leader in life sciences research and manufacturi...

August 27, 2024 | Tuesday | News
New Zealand to update clinical trial regulatory guidelines

A plan aiming to streamline clinical trial reporting procedures in some circumstances is now out for consultation in New...

August 26, 2024 | Monday | News
Belgium-based UCB to divest mature neurology and allergy business in China for $680 M

UCB, a global biopharmaceutical company based in Belgium, has announced a strategic divestment deal in China, underscori...

August 26, 2024 | Monday | News
RedHill announces launch of Talicia in UAE to treat bacterial infection

RedHill Biopharma, a US-based specialty biopharmaceutical company, has announced the launch of Talicia (omeprazole magne...

August 21, 2024 | Wednesday | News
Biomanufacturing incubator opens at University of Sydney

The Biomanufacturing Incubator, recently opened at the University of Sydney, Australia, will pair cell biologists who ...

August 21, 2024 | Wednesday | News
MEDICAL JAPAN 2024 TOKYO Expands Horizons with New Trade Fairs and Comprehensive Healthcare Coverage

Like in the previous edition, MEDICAL JAPAN TOKYO features six sub shows. First off is the HOSPITAL EXPO, which i...

August 14, 2024 | Wednesday | News
UAE approves Leqembi for treatment of Alzheimer's disease

Japan-based Eisai and US-based Biogen have announced that the Ministry of Health and Prevention in the United Arab Emira...

August 14, 2024 | Wednesday | News